Elif Dokmeci

443 total citations
4 papers, 69 citations indexed

About

Elif Dokmeci is a scholar working on Immunology, Surgery and Genetics. According to data from OpenAlex, Elif Dokmeci has authored 4 papers receiving a total of 69 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Immunology, 1 paper in Surgery and 1 paper in Genetics. Recurrent topics in Elif Dokmeci's work include Urticaria and Related Conditions (1 paper), Food Allergy and Anaphylaxis Research (1 paper) and Hematopoietic Stem Cell Transplantation (1 paper). Elif Dokmeci is often cited by papers focused on Urticaria and Related Conditions (1 paper), Food Allergy and Anaphylaxis Research (1 paper) and Hematopoietic Stem Cell Transplantation (1 paper). Elif Dokmeci collaborates with scholars based in United States. Elif Dokmeci's co-authors include Christina A. Herrick, Eve Robinson, Lan Xu, Kim Bottomly, John F. Kuttesch, Jennifer Han and Stuart S. Winter and has published in prestigious journals such as PLoS ONE, Immunology and Seminars in Cutaneous Medicine and Surgery.

In The Last Decade

Elif Dokmeci

3 papers receiving 66 citations

Peers

Elif Dokmeci
Robert Higham United States
David Buckley United States
Sady Alpizar United States
Caoimhe Fahy Ireland
Elif Dokmeci
Citations per year, relative to Elif Dokmeci Elif Dokmeci (= 1×) peers Laurie Eicher

Countries citing papers authored by Elif Dokmeci

Since Specialization
Citations

This map shows the geographic impact of Elif Dokmeci's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elif Dokmeci with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elif Dokmeci more than expected).

Fields of papers citing papers by Elif Dokmeci

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elif Dokmeci. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elif Dokmeci. The network helps show where Elif Dokmeci may publish in the future.

Co-authorship network of co-authors of Elif Dokmeci

This figure shows the co-authorship network connecting the top 25 collaborators of Elif Dokmeci. A scholar is included among the top collaborators of Elif Dokmeci based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elif Dokmeci. Elif Dokmeci is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

4 of 4 papers shown
1.
Han, Jennifer, et al.. (2018). Dynamic re-immunization of off-treatment childhood cancer survivors: An implementation feasibility study. PLoS ONE. 13(2). e0191804–e0191804. 7 indexed citations
3.
Dokmeci, Elif, et al.. (2011). EBI3 deficiency leads to diminished T helper type 1 and increased T helper type 2 mediated airway inflammation. Immunology. 132(4). 559–566. 26 indexed citations
4.
Dokmeci, Elif & Christina A. Herrick. (2008). The Immune System and Atopic Dermatitis. Seminars in Cutaneous Medicine and Surgery. 27(2). 138–143. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026